Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SBUX vs GSK✓SelectedUSD · GSKSBUX vs GSK performance historyLatest closeAs of-1.28%11/20
Stock and ETF performance explorer

SBUX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+6.7%
GSK return
+53.4%
Excess return
-46.7%
Maximum drawdown
-31.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.3%-0.1%-1.2%-1.3%
7D-3.1%-5.3%+2.2%-2.3%
30D+4.7%-3.7%+8.4%+5.3%
3M-0.2%-7.3%+7.0%+0.7%
6M-2.0%-4.2%+2.2%-1.6%
YTD+25.4%+0.9%+24.6%+25.0%
1Y+27.8%+7.3%+20.6%+26.5%
3Y+6.7%+52.7%-46.1%-1.5%
All+6.7%+53.4%-46.7%-1.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling